Smith & Nephew (SNN) Non-Current Deferred Tax Liability (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Non-Current Deferred Tax Liability of $40.0 million for Q4 2025, up 29.03% year-on-year from $31.0 million in Q4 2024, and down 4.76% on a QoQ basis from $42.0 million in Q2 2025.
Smith & Nephew (SNN) Non-Current Deferred Tax Liability (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Non-Current Deferred Tax Liability for 17 consecutive years, with $40.0 million the latest figure, recorded in Q4 2025.
- Quarterly Non-Current Deferred Tax Liability rose 29.03% year-over-year to $40.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.0 million (up 29.03% YoY) and the FY2025 annual result came in at $40.0 million, up 29.03% from the prior year.
- Non-Current Deferred Tax Liability eased to $40.0 million in Q4 2025 per SNN's latest filing, from $42.0 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for SNN reached as high as $144.0 million in Q4 2021 and fell as low as $9.0 million in Q4 2023.
- A 5-year average of $48.3 million and a median of $36.0 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability plunged 75.0% — and 2024, when it jumped 244.44%.
- Year by year, Non-Current Deferred Tax Liability stood at $144.0 million in 2021, then tumbled by 75.0% to $36.0 million in 2022, then tumbled by 75.0% to $9.0 million in 2023, then soared by 244.44% to $31.0 million in 2024, then rose by 29.03% to $40.0 million in 2025.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $40.0 million, $42.0 million, and $31.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.00 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Jun 28, 2025 | 42.00 Mn |
| Jun 28, 2025 | 42.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Jun 29, 2024 | 36.00 Mn |
| Jun 29, 2024 | 36.00 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 36.00 Mn |
| Dec 31, 2022 | 36.00 Mn |
| Dec 31, 2021 | 144.00 Mn |
| Dec 31, 2021 | 144.00 Mn |
| Dec 31, 2020 | 141.00 Mn |
| Dec 31, 2020 | 141.00 Mn |
| Jun 30, 2020 | 163.00 Mn |
| Jun 30, 2020 | 163.00 Mn |
| Dec 31, 2019 | 167.00 Mn |
| Dec 31, 2019 | 167.00 Mn |